ArticleThe Journal of international medical research2020

Platelet/lymphocyte ratio is a significant prognostic factor for targeted therapy in patients with EGFR-mutated non-small-cell lung cancer.

Kejun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.